Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Simplified Flow Cytometric Assessment in Mycosis Fungoides and Sézary Syndrome
Alexandra C. Hristov, Eric C. Vonderheid, Michael J. Borowitz
American Journal of Clinical Pathology (2011) Vol. 136, Iss. 6, pp. 944-953
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic, Lauren Pinter‐Brown, Francine M. Foss, et al.
Blood (2015) Vol. 125, Iss. 12, pp. 1883-1889
Open Access | Times Cited: 215
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
Tushar D. Nichakawade, Jiaxin Ge, Brian J. Mog, et al.
Nature (2024) Vol. 628, Iss. 8007, pp. 416-423
Closed Access | Times Cited: 21
Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2017) Vol. 92, Iss. 10, pp. 1085-1102
Open Access | Times Cited: 141
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2019) Vol. 94, Iss. 9, pp. 1027-1041
Open Access | Times Cited: 118
Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity
Joonhee Park, Jay Daniels, Tim Wartewig, et al.
Blood (2021) Vol. 138, Iss. 14, pp. 1225-1236
Open Access | Times Cited: 69
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 193-209
Open Access | Times Cited: 51
Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T‐cell malignancies
Liyanage P. Perera, Meili Zhang, Masao Nakagawa, et al.
American Journal of Hematology (2017) Vol. 92, Iss. 9, pp. 892-901
Open Access | Times Cited: 78
Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2014) Vol. 89, Iss. 8, pp. 837-851
Open Access | Times Cited: 67
Chimeric Antigen Receptors for T-Cell Malignancies
Lauren Scherer, Malcolm K. Brenner, Maksim Mamonkin
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 65
Single Antibody Detection of T‐Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T‐Cell Neoplasms and Monotypic Small CD8‐Positive Subsets of Uncertain Significance
Min Shi, Dragan Jevremović, Gregory E. Otteson, et al.
Cytometry Part B Clinical Cytometry (2019) Vol. 98, Iss. 1, pp. 99-107
Open Access | Times Cited: 65
Flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: International guidelines for assay characteristics
Pedro Horna, Sa A. Wang, Kristy Wolniak, et al.
Cytometry Part B Clinical Cytometry (2020) Vol. 100, Iss. 2, pp. 142-155
Open Access | Times Cited: 44
The role of Dipeptidyl Peptidase‐4 in cutaneous disease
Payal M. Patel, Virginia Jones, Khalaf Kridin, et al.
Experimental Dermatology (2020) Vol. 30, Iss. 3, pp. 304-318
Open Access | Times Cited: 40
Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2020) Vol. 95, Iss. 10, pp. 1209-1213
Open Access | Times Cited: 39
Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2021) Vol. 96, Iss. 10, pp. 1313-1328
Open Access | Times Cited: 38
Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach
Maarten H. Vermeer, Hélène Moins‐Teisserenc, M. Bagot, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 1, pp. 21-28
Open Access | Times Cited: 23
Mature T-Cell Neoplasms and Natural Killer-Cell Malignancies
Anne Tierens
Cambridge University Press eBooks (2025), pp. 141-163
Closed Access
Blood Flow Cytometry in Sézary Syndrome
Mauro Novelli, Paolo Fava, Cristina Sarda, et al.
American Journal of Clinical Pathology (2014) Vol. 143, Iss. 1, pp. 57-69
Open Access | Times Cited: 48
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
Pietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 3, pp. 484-495
Open Access | Times Cited: 34
Duration of Response in Cutaneous T-Cell Lymphoma Patients Treated With Denileukin Diftitox: Results From 3 Phase III Studies
Madeleine Duvic, Larisa J. Geskin, H. Miles Prince
Clinical Lymphoma Myeloma & Leukemia (2013) Vol. 13, Iss. 4, pp. 377-384
Closed Access | Times Cited: 38
Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents
Sumana Devata, Ryan A. Wilcox
American Journal of Clinical Dermatology (2016) Vol. 17, Iss. 3, pp. 225-237
Closed Access | Times Cited: 34
Utility of TRBC1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lymphoma
Pedro Horna, Min Shi, Dragan Jevremović, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 4, pp. 821-829.e2
Open Access | Times Cited: 31
Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients
Philippe Lefrançois, Pingxing Xie, Linghua Wang, et al.
OncoImmunology (2018), pp. e1467856-e1467856
Open Access | Times Cited: 28
Mycosis fungoides and Sézary syndrome
Hye Won Lee
Blood Research (2023) Vol. 58, Iss. S1, pp. S66-S82
Open Access | Times Cited: 8
Resistance of Sézary cells to TNF‐α‐induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression
Oleg E. Akilov, Mei X. Wu, Irina V. Ustyugova, et al.
Experimental Dermatology (2012) Vol. 21, Iss. 4, pp. 287-292
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top